We recently joined the @PKDFoundation community at PKDCon, which brought together people living with ADPKD, their caregivers, and family members; and the PKD Centers of Excellence, a conference for nephrologists and investigators focused on advancing standards of care. (1/5)

We appreciated hearing from people living with ADPKD, connecting with clinicians, and sharing more about our research investigating PAPP-A. (2/5)

PAPP-A is a protein that influences insulin-like growth factor (IGF) signaling, which may play a role in kidney cyst development and growth in ADPKD. This potential role has not been established and remains under investigation. (3/5)

Learn more about how we’re advancing clinical research in ADPKD and our ongoing global Phase 2 trial: calicolabs.com/clinical-tria… (4/5)